Stockscreener 앱 받기
3.72
3.12%
-0.12
시장 영업 전:
3.73
0.010
+0.27%
Avita Medical Inc 주식(RCEL)의 최신 뉴스
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
AVITA Medical (RCEL) Reports Strong Q4 2025 Performance - GuruFocus
Avita Medical Q4 Earnings Call Highlights - MarketBeat
Avita Medical (RCEL) Reports Lower Q4 Revenue Amidst Operational Transition - GuruFocus
AVITA Medical (RCEL) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth - Investing.com India
AVITA Medical, Inc. SEC 10-K Report - TradingView
AVITA Medical Q4 Earnings Summary & Key Takeaways - Benzinga
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Is AVITA Medical Inc. stock a buy before product launchesTrade Risk Report & Fast Exit and Entry Trade Guides - mfd.ru
Lake Street Raises Price Target on AVITA Medical, Inc. (RCEL) to $3.50, Maintains Hold Rating - Finviz
Lake Street raises price target on AVITA Medical, Inc. (RCEL) to $3.50, maintains hold rating - MSN
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
AVITA Medical, Inc.'s (NASDAQ:RCEL) Shift From Loss To Profit - Yahoo Finance
Avita Medical Stock: Skin Regeneration Platform Is Set Up For A Turnaround (NASDAQ:RCEL) - Seeking Alpha
Buy Signal: Can AVITA Medical Inc weather a recession2025 Key Highlights & Fast Entry High Yield Tips - baoquankhu1.vn
Insider Buy: Is Ellomay Capital Ltd a speculative investmentPortfolio Risk Report & High Conviction Trade Alerts - baoquankhu1.vn
Aug Summary: What is NVAWWs P E ratio telling usMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
AVITA Medical (RCEL) Analyst Rating: Maintained 'Buy' with $10 P - GuruFocus
D. Boral Capital Reaffirms Buy Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
New Highs: Will AVITA Medical Inc benefit from rate cuts2025 Year in Review & Safe Capital Allocation Plans - baoquankhu1.vn
AVITA Medical (RCEL) Showcases Breakthrough Data at 2026 Burn Sy - GuruFocus
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies - Investing News Network
First three-part AVITA burn care path cuts painful dressing changes - stocktitan.net
There's No Escaping AVITA Medical, Inc.'s (NASDAQ:RCEL) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
Momentum Shift: Can AVITA Medical Inc maintain sales growth2025 Key Lessons & Low Drawdown Trading Strategies - baoquankhu1.vn
Volatility Watch: Is AVITA Medical Inc stock forming a triangle patternWeekly Profit Analysis & Scalable Portfolio Growth Methods - baoquankhu1.vn
AVITA Medical, Inc.'s (NASDAQ:RCEL) Path To Profitability - simplywall.st
RCEL Analyst Rating Update: Lake Street Raises Price Target | RC - GuruFocus
AVITA Medical (ASX:AVH) Posts Revenue Growth and Advances Clinical Pipeline Ahead of Key Data in 2026 - Kalkine Media
AVITA Medical (RCEL): Analyst Lowers Price Target, Maintains Buy Rating | RCEL Stock News - GuruFocus
D. Boral Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price - MarketBeat
RCEL: 2026 guidance targets $80–$85M revenue, driven by clinical innovation and focused execution - TradingView — Track All Markets
Aug Drivers: Does AUTAP have strong EBITDA marginsJuly 2025 Outlook & Safe Entry Point Identification - baoquankhu1.vn
AVITA Medical, Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook - marketscreener.com
AVITA Medical reports Q4 revenue of $17.6 million, secures new debt - Investing.com Nigeria
Avita's Road to Profitability Is in Sight - Morningstar
Entry Recap: Should I hold or sell AVITA Medical Inc stock in 2025Analyst Downgrade & Daily Market Momentum Tracking - Bộ Nội Vụ
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook - Investing News Network
Avita Medical, Inc. Announces Closing of New Credit Facility with Perceptive Advisors - marketscreener.com
Avita Medical Secures New Credit Facility and Warrants - TipRanks
Avita Medical (RCEL) Projects Strong Revenue Growth for FY26 - GuruFocus
RCEL Prepares for Growth with Strengthened Business Foundation - GuruFocus
AVITA Medical (RCEL) Secures $60M Credit Facility to Boost Growt - GuruFocus
Avita Medical Inc enters into credit agreement and guarantySEC filing - marketscreener.com
Avita Medical IncEnters Into Credit Agreement And GuarantySEC Filing - TradingView
AVITA Medical Signs Credit Agreement and Guaranty With Perceptive Credit Holdings V - TradingView — Track All Markets
AVITA Medical, Inc. Enters into a Credit Agreement and Guaranty and a Security Agreement - marketscreener.com
AVITA Medical outlines $80–85M 2026 sales and new $60M credit deal - Stock Titan
Can AVITA Medical Inc stock weather global recessionEarnings Performance Report & High Win Rate Trade Tips - Bộ Nội Vụ
0.45%
0.31%
자본화:
|
볼륨(24시간):